Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling
Diego A. Pedroza et al.
BRITISH JOURNAL OF CANCER (2020)
Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
Hannah Asperger et al.
BREAST CANCER RESEARCH (2020)
PGRMC1 can trigger estrogen-dependent proliferation of breast cancer cells: estradiol vs. equilin vs. ethinylestradiol
X. Li et al.
CLIMACTERIC (2019)
Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation
Mauro E. Cenciarini et al.
STEROIDS (2019)
Overcoming endocrine resistance in hormone receptor-positive breast cancer
A. AlFakeeh et al.
CURRENT ONCOLOGY (2018)
Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study
Marit Busund et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Communication between genomic and non-genomic signaling events coordinate steroid hormone actions
Sandi R. Wilkenfeld et al.
STEROIDS (2018)
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)
Xu Liang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer
Xiangyan Ruan et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)
Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells
Marina Willibald et al.
ONCOTARGET (2017)
Rapid steroid hormone actions via membrane receptors
Nofrat Schwartz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Spectroscopic and Mutagenesis Studies of Human PGRMC1
Daniel Kaluka et al.
BIOCHEMISTRY (2015)
Receptor activator for nuclear factor-κB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis
Thiyagarajan Boopalan et al.
CANCER SCIENCE (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies
Weimin Fan et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Progesterone receptor modulates ERα action in breast cancer
Hisham Mohammed et al.
NATURE (2015)
Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials
Rowan T. Chlebowski et al.
JAMA ONCOLOGY (2015)
G Protein-Coupled Receptors: Extranuclear Mediators for the Non-Genomic Actions of Steroids
Chen Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Genomic and non-genomic actions of progestogens in the breast
A. O. Mueck et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Nadia Howlader et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Characterization, Neurosteroid Binding and Brain Distribution of Human Membrane Progesterone Receptors δ and ε (mPRδ and mPRε) and mPRδ Involvement in Neurosteroid Inhibition of Apoptosis
Yefei Pang et al.
ENDOCRINOLOGY (2013)
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells
Helen Schneck et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1
Jing Zhou et al.
MATURITAS (2013)
Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy
Hans Neubauer et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2013)
Estrogen-Induced Nongenomic Calcium Signaling Inhibits Lipopolysaccharide-Stimulated Tumor Necrosis Factor α Production in Macrophages
Limin Liu et al.
PLOS ONE (2013)
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
Peter Kabos et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells
X. Ruan et al.
CLIMACTERIC (2012)
Progesterone Receptor Isoform Functions in Normal Breast Development and Breast Cancer
Anastasia Kariagina et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
S2RPgrmc1: the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling
Ikhlas S. A. Ahmed et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells
Xiangyan Ruan et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients
Shakeel U. R. Mir et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Differential Regulation of Breast Cancer-Associated Genes by Progesterone Receptor Isoforms PRA and PRB in a New Bi-Inducible Breast Cancer Cell Line
Junaid A. Khan et al.
PLOS ONE (2012)
The Stimulation of HSD17B7 Expression by Estradiol Provides a Powerful Feed-Forward Mechanism for Estradiol Biosynthesis in Breast Cancer Cells
Aurora Shehu et al.
MOLECULAR ENDOCRINOLOGY (2011)
Pgrmc1 (Progesterone Receptor Membrane Component 1) Associates with Epidermal Growth Factor Receptor and Regulates Erlotinib Sensitivity
Ikhlas S. Ahmed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1
John J. Peluso et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats
Edward W. Blank et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
Hans Neubauer et al.
BREAST CANCER RESEARCH (2008)
Progesterone receptor membrane component 1: An integrative review
Michael A. Cahill
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes
Adam L. Hughes et al.
CELL METABOLISM (2007)
Mechanisms of disease: Estrogen carcinogenesis in breast cancer
JD Yager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Molecular identification of adrenal inner zone antigen as a heme-binding protein
L Min et al.
FEBS JOURNAL (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Overexpression of the cytochrome P450 activator Hr6 (heme-1 domain protein/hman progesterone receptor) in tumors
G Crudden et al.
TUMOR BIOLOGY (2005)
Effect of progesterone receptor A predominance on breast cancer cell migration into bone marrow fibroblasts
EM McGowan et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones
AH Payne et al.
ENDOCRINE REVIEWS (2004)
Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden
NR Shah
CANCER (2003)
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases
VJ Bardou et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis
PA Mote et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)